|
Dr. Daniel Schwartz
|
Development of an Aqueous Suspension of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) (2005)
|
|
Dr. Richard Fuhrherr
|
Spray-dried antibody powders for pulmonary application (2005)
|
|
Dr. Iris Metzmacher
|
Enzymatic Degradation and Drug Release Behavior of Dense Collagen Implants (2005)
|
|
Dr. Stefanie Schüle
|
Stabilization of Antibodies in Spray-dried Powders for Inhalation (2005)
|
|
Dr. Susanne Matheus
(since 2009: Susanne Jörg)
|
Development of High Concentration Cetuximab Formulations using Ultrafiltration and Precipitation Techniques (2006)
|
|
Dr. Andrea Hawe
|
Studies on Stable Formulations for a Hydrophobic Cytokine (2006)
|
|
Dr. Matthias Ganz
|
Wirbelschichttrocknung von Proteinen (2007)
|
|
Dr. Andreas Rutz
|
Ölige Suspensionen als parenterale Depotsysteme für rekombinante Proteine (2007)
|
|
Dr. Cornelius Pompe
|
Development of New In-situ Hardening and Bioactivated Composite Materials for Orthopedic Indications (2008)
|
|
Dr. Florian Matl
|
Infected Biomaterials - New strategies for local anti-infective treatment (2008)
|
|
Dr. Virginie Le Brun
|
Physical Properties of Protein Formulations (2009)
|
|
Dr. Sylvia Kiese
|
Protein aggregation: Methods, Prediction and Inhibition (2009)
|
|
Dr. Frank Schaubhut
|
VEGF Carrying Coatings for Enhanced Vascular Graft Endothelialization (2010)
|
|
Dr. Johannes Mathes
|
Protein Adsorption to Vial Surfaces – Quantification, Structural and Mechanistic Studies (2010)
|
|
Dr. Katja Schmid
|
Spray drying of protein precipitates and Evaluation of the Nano Spray Dryer B-90 (2011)
|
|
Dr. Miriam Printz
|
The Value of Fluorescence and B22 Techniques as Complementary Approaches in Protein Stability Analysis (2011)
|
|
Dr. Lars Schiefelbein
|
Sugar-based surfactants for pharmaceutical Protein formulations (2011)
|
|
Dr. Julia Kasper
|
Lyophilization of Nucleic Nanoparticles - Formulation Development, Stabilization Mechanisms, and Process Monitoring (2012)
|
|
Dr. Winfried Schlögl
|
Development of Advanced Biomaterials for Bone Tissue Engineering (2012)
|
|
Dr. Kerstin Vay
|
Analysis and control of the manufacturing process and the release properties of PLGA microparticles for sustained delivery of a poorly water-soluble drug (2012)
|
|
Dr. Sarah Claus
|
Novel Dry Powder Inhalation System Based on Dispersion of Lyophilisates (2012)
|
|
Dr. Eva-Maria Ruberg
|
Development of sustained release formulations for the intra-articular delivery of a therapeutic antibody (2013)
|
|
Dr. Kristine Berkenhoff
|
Subcutaneous suspensions of therapeutic proteins formulated as protein-coated microcrystals (2013)
|
|
Dr. Sarah Zölls
|
Protein Particle Analysis - Critical Factors and New Standards (2013)
|
|
Dr. Katharina Ziegler
|
Untersuchungen zur Stabilisierung und Interaktion von Cetuximab mit nicht-ionischen Tensiden (2013)
|
|
Dr. Kerstin Höger
|
Investigations on Protein Adsorption to Coated Glass Vials (2014)
|
|
Dr. Fabian Higel
|
Pharmacokinetic profiling of therapeutic proteins and variants by mass spectrometry (2014)
|
|
Dr. Tim Menzen
|
Temperature-Induced Unfolding, Aggregation, and Interaction of Therapeutic Monoclonal Antibodies (2014)
|
|
Dr. Gudrun Birk
|
Formulation development of a highly concentrated suspension of Cilengitide. (2014)
|
|
Dr. Philipp Matthias
|
In situ-hardening hydrogels for the sustained release of protein pharmaceutics. (2014)
|
|
Dr. Verena Saller
|
Interactions of formulation and disposables in biopharmaceutical drug product manufacturing. (2015)
|
|
Dr. Madeleine Witting
|
Local and targeted delivery of proteins (2016)
|
|
Dr. Stefanie Funke
|
Cartridges filling with biopharmaceuticals with focus on the optimization of the siliconization process (2016)
|
|
Dr. Christoph Korpus
|
Freeze-Drying in Dual Chamber Cartridges - from Energy Transfer to Process Control - (2017)
|
|
Dr. Bifeng Wang
|
Particle engineering technologies to improve protein drug delivery; spray drying and fluidized bed drying (2017)
|
|
Dr. Kerstin Hoffmann
|
Sustained release lipid microparticles (2017)
|
|
Dr. Ellen Köpf
|
Antibody drugs at the liquid-air interface: physicochemical characteristics, aggregation & the impact of formulation (2017)
|
|
Dr. Corinna Dürr
|
Studies on the Physicochemical Stability of Antibody conjugates (2018)
|
|
Dr. Jacqueline Horn
|
New aspects of process and formulation development of freeze-drying of proteins (2018)
|
|
Dr. Kay Strüver
|
DEVELOPMENT AND CHARACTERIZATION OF IN-VITRO MODELS FOR FILAGGRIN ASSOCIATED SKIN DISEASES (2018)
|
|
Dr. Yordanka Yordanova
|
Oil-Based Parenteral Depot Formulation for Veterinary Peptide Delivery(2018)
|
|
Dr. Christoph Marschall
|
Protein delivery with biocompatible non-aqueous solvents (2019)
|
|
Dr. Lorenzo Gentiluomo
|
Prediction and Characterization of Theraputic Protein Aggregation (2020)
|
|
Dr. Ivonne Seifert
|
Understanding the Effect of Arginine and the Freeze Concentrate on Antibody Lyophilisates (2020) |
|
Dr. Martin Domnowski
|
Self-Interaction and targeted Engineering of monoclonal Antibodies (2020)
|
|
Dr. Sarah Ehlers (geb. Daller)
|
Nests and Chamber Wall Temperature Control as Tools in Pharmaceutical Freeze-Drying – Evaluation of Heat Transfer, Edge-Vial-Effect and Drying Kinetics (2020)
|
| Dr. Eduard Trenkenschuh |
Freeze-drying of nanoparticles: Impact of particle properties on formulation and process development (2021) |
| Dr. Robina Meyer |
Separation and Characterization of Subpopulations of Biopharmaceuticals (2021) |
| Dr. Oliver Blümel |
Optimised Freezing and Thawing of Monoclonal Antibody Solutions (2021) |
